Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Crispr Therapy Shown to Reduce Harmful Gut Microbes

E. coli bacteria illustration

A clinical trial shows an oral therapy with engineered viruses delivers precise gene-edited payloads to reduce E. coli communities in the gut with no serious adverse effects. . . . → Read More: Crispr Therapy Shown to Reduce Harmful Gut Microbes

Precision T-Cell Solid Tumor Therapy Trial Underway

T lymphocyte

A clinical trial has begun testing a treatment for solid tumor cancers using engineered T-cells with proteins to attack specific tumor cells, but also avoid healthy cells. . . . → Read More: Precision T-Cell Solid Tumor Therapy Trial Underway

Memorial Day, 2023

Vietnam War Wall

We’ll resume our editorial posting tomorrow. . . . → Read More: Memorial Day, 2023

Infographic – More US Support for Childhood Vaccines Than Covid-19

Bar charts: U.S. opinion on MMR and Covid-19 vaccines

A recent poll shows U.S. adults continue to favor vaccinations against the childhood diseases mumps, measles, and rubella, but show less support for Covid-19 vaccines. . . . → Read More: Infographic – More US Support for Childhood Vaccines Than Covid-19

AI-Designed Cancer Vaccine Shown to Act Against Melanoma

T-cells and cancer cells

Results of a small clinical trial show most patients with melanoma receiving a personalized therapeutic vaccine with an approved immunotherapy reduced at least some of their tumors. . . . → Read More: AI-Designed Cancer Vaccine Shown to Act Against Melanoma

Low-Dose Oral Film Reduces Mental Disorder Agitation

Depression

Interim results from a clinical trial show a drug given as a dissolvable oral film in a lower dose reduces agitation in people with bipolar disorder and schizophrenia. . . . → Read More: Low-Dose Oral Film Reduces Mental Disorder Agitation

Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

Editing DNA

A global drug maker is acquiring access to a biotechnology company’s precise genome editing techniques to develop new therapies for rare and cardiometabolic disorders. . . . → Read More: Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

Lab to Develop New Bio-Based Sustainable Materials

Climate change illustration

A venture investment fund and university bioengineering center are creating a laboratory to design more sustainable alternative materials to help address the climate crisis. . . . → Read More: Lab to Develop New Bio-Based Sustainable Materials

Safer Forms of Psilocybin Assessed in Preclinical Study

Psilocybin mushrooms

A biotechnology company says it identified engineered precursors of a psychedelic compound that in lab animals produce safe and intended therapeutic effects. . . . → Read More: Safer Forms of Psilocybin Assessed in Preclinical Study

Infographic – U-Turn on A.I. Venture Funds in Q1

Chart: Venture funds for artificial intelligence by quarter to Q1 2023

Both the total investment dollars and number of venture deals in Q1 2023 are the lowest single quarter totals since 2019. . . . → Read More: Infographic – U-Turn on A.I. Venture Funds in Q1